131 related articles for article (PubMed ID: 15752709)
1. Histone acetyltransferase p300 promotes the activation of human WT1 promoter and intronic enhancer.
Shao Y; Lu J; Zhang G; Liu C; Huang B
Arch Biochem Biophys; 2005 Apr; 436(1):62-8. PubMed ID: 15752709
[TBL] [Abstract][Full Text] [Related]
2. Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1.
Liu C; Lu J; Tan J; Li L; Huang B
Cytokine; 2004 Aug 21-Sep 7; 27(4-5):93-100. PubMed ID: 15271374
[TBL] [Abstract][Full Text] [Related]
3. Histone acetyltransferase activity of p300 enhances the activation of IL-12 p40 promoter.
Sun H; Lu J; Wei L; Wang X; Xu X; Dong M; Huang B
Mol Immunol; 2004 Nov; 41(12):1241-6. PubMed ID: 15482860
[TBL] [Abstract][Full Text] [Related]
4. Histone acetyltransferase activity of p300 enhances the activation of IL-18 promoter.
Sun H; Lu J; Xu X; Jin S; Wang X; Wei L; Dong M; Huang B
J Cell Biochem; 2005 Feb; 94(3):566-72. PubMed ID: 15543578
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of cytosolic alanine aminotransferase gene promoter by p300 and c-Myb.
Anemaet IG; González JD; Salgado MC; Giralt M; Fernández F; Baanante IV; Metón I
J Mol Endocrinol; 2010 Sep; 45(3):119-32. PubMed ID: 20573775
[TBL] [Abstract][Full Text] [Related]
6. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.
Tomita A; Towatari M; Tsuzuki S; Hayakawa F; Kosugi H; Tamai K; Miyazaki T; Kinoshita T; Saito H
Oncogene; 2000 Jan; 19(3):444-51. PubMed ID: 10656693
[TBL] [Abstract][Full Text] [Related]
7. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system.
Kirch HC; Ruschen S; Brockmann D; Esche H; Horikawa I; Barrett JC; Opalka B; Hengge UR
Oncogene; 2002 Nov; 21(52):7991-8000. PubMed ID: 12439749
[TBL] [Abstract][Full Text] [Related]
9. Multitasking C2H2 zinc fingers link Zac DNA binding to coordinated regulation of p300-histone acetyltransferase activity.
Hoffmann A; Barz T; Spengler D
Mol Cell Biol; 2006 Jul; 26(14):5544-57. PubMed ID: 16809786
[TBL] [Abstract][Full Text] [Related]
10. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
Deuel TF; Guan LS; Wang ZY
Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
[TBL] [Abstract][Full Text] [Related]
11. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
Yang C; Romaniuk PJ
Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
[TBL] [Abstract][Full Text] [Related]
12. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor protein Wt1 regulates the Interleukin-10 (IL-10) gene.
Sciesielski LK; Kirschner KM; Scholz H; Persson AB
FEBS Lett; 2010 Nov; 584(22):4665-71. PubMed ID: 20974136
[TBL] [Abstract][Full Text] [Related]
14. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
15. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
[TBL] [Abstract][Full Text] [Related]
16. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
17. A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros.
Bollig F; Perner B; Besenbeck B; Köthe S; Ebert C; Taudien S; Englert C
Development; 2009 Sep; 136(17):2883-92. PubMed ID: 19666820
[TBL] [Abstract][Full Text] [Related]
18. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.
Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH
Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918
[TBL] [Abstract][Full Text] [Related]
19. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.
Wagner N; Wagner KD; Xing Y; Scholz H; Schedl A
J Am Soc Nephrol; 2004 Dec; 15(12):3044-51. PubMed ID: 15579507
[TBL] [Abstract][Full Text] [Related]
20. The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex.
Lang SE; Hearing P
Oncogene; 2003 May; 22(18):2836-41. PubMed ID: 12743606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]